These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31073413)

  • 1. Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma.
    Zaleska-Żmijewska A; Strzemecka E; Wawrzyniak ZM; Szaflik JP
    J Ophthalmol; 2019; 2019():1240537. PubMed ID: 31073413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma.
    Janulevičienė I; Derkač I; Grybauskiene L; Paulauskaitė R; Gromnickaite R; Kuzmienė L
    Clin Ophthalmol; 2012; 6():103-9. PubMed ID: 22275814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ocular surface disease in elderly patients with glaucoma: expression of matrix metalloproteinase-9 in tears.
    Kim DW; Seo JH; Lim SH
    Eye (Lond); 2021 Mar; 35(3):892-900. PubMed ID: 32472047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.
    Walimbe T; Chelerkar V; Bhagat P; Joshi A; Raut A
    Clin Ophthalmol; 2016; 10():821-7. PubMed ID: 27274186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
    Wu JH; Wang TH; Huang JY; Su CC
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation.
    Mullick R; Annavajjhala S; Thakur P; Mohapatra A; Shetty R; D'Souza S
    Indian J Ophthalmol; 2021 Dec; 69(12):3473-3477. PubMed ID: 34826977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
    Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
    Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
    Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
    Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
    Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
    Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients.
    Horsley MB; Kahook MY
    Clin Ophthalmol; 2009; 3():291-5. PubMed ID: 19668581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients.
    Ruangvaravate N; Choojun K; Srikulsasitorn B; Chokboonpiem J; Asanatong D; Trakanwitthayarak S
    Clin Ophthalmol; 2020; 14():3109-3119. PubMed ID: 33116362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials.
    Uusitalo H; Egorov E; Kaarniranta K; Astakhov Y; Ropo A
    Clin Ophthalmol; 2016; 10():445-54. PubMed ID: 27041987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma.
    Pérez-Bartolomé F; Martínez-de-la-Casa JM; Arriola-Villalobos P; Fernández-Pérez C; Polo V; García-Feijoó J
    Eur J Ophthalmol; 2017 Nov; 27(6):694-704. PubMed ID: 28497458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)].
    Dorofeev DA; Tur EV; Vizgalova LO; Tryapitsin ID; Ciganov AZ
    Vestn Oftalmol; 2019; 135(6):52-59. PubMed ID: 32015308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue.
    Lopes NLV; Gracitelli CPB; Chalita MR; de Faria NVL
    Med Hypothesis Discov Innov Ophthalmol; 2019; 8(1):52-56. PubMed ID: 30923724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension.
    Muz OE; Dagdelen K; Pirdal T; Guler M
    Int Ophthalmol; 2021 Nov; 41(11):3825-3835. PubMed ID: 34263385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latanoprost PF vs. Bimatoprost PF: Which Treats the Ocular Surface Better?
    Dimtsas GS; Tsiogka A; Moschos MM
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study.
    Su CC; Lee YC; Lee PRC
    Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1243-1251. PubMed ID: 33433642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes.
    Ansari E; Chappiti S; Pavicic-Astalos J; Pinto-Bonilla JC; Riva I; Sacchi M; Saénz-Francés F
    BMC Ophthalmol; 2022 Apr; 22(1):152. PubMed ID: 35366846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.